France Contraceptive Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

France Contraceptive Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The France contraceptive devices market is expected to register a CAGR of 8.1% over the forecast period.

The outbreak of the COVID-19 pandemic has pushed the medical device industry into action, with a race to develop both therapeutic and preventive devices in France. Exponentially increasing cases of the coronavirus in France are leading to the need for the development of novel treatments, with several clinical trials underway. Meanwhile, the manufacturers of medical devices were highly focused on developing vaccines and drugs, which can also be applied in the diagnosis and treatment of COVID-19, increasing the rate of clinical trials to a great extent. The outbreak of the pandemic adversely impacted the contraceptive devices market in France. For instance, as per the study titled, "Impact of Coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France" published in April 2022, the dispensing of contraceptives in France was remarkably low during the COVID-19 pandemic.

In addition, the number of sexually transmitted diseases also showed a decline during the pandemic. For instance, as per the study titled, "The impact of the COVID-19 pandemic on Sexually Transmitted Infections surveillance data: incidence drop or artefact?" published in September 2021, the number of sexually transmitted diseases showed a sharp decline during the pandemic and was maintained almost five months after lockdown was started in France. However, with the ease of restrictions and lockdowns the cases of sexually transmitted diseases started to increase which postively impacted the market. Therefore, the market witnessed a moderate growth during the pandemic.

The increasing awareness about sexually transmitted diseases (STDs) and rising rate of unintended pregnancies and rise in government initiatives are the major factors driving the market growth. For instance, in November 2021, a report published titled "HIV/AIDS surveillance in Europe 2021" stated that the sex between men and women is the second most commonly reported mode of transmission in the European Union, accounting for 29.7% (4445) of all HIV diagnoses. The highest proportions of these were observed in France (53.0%).

Similarly, the report “Human Papillomavirus (HPV) and Related Diseases Report France” published in October 2021, suggested that the prevalence of HPV 16 and 18 among adult women with normal cytology is 4.7%, with low-grade cervical lesions is 26.3%, with high grade cervical lesions is 60.6% and with cervical cancer is 75.6%. Such instances indicate that the demand for contraceptive devices may increase, thereby considerable market growth is anticipated over the forecast period.

However, side effects associated with the use of contraceptive devices may likely to restrain the market growth over the forecast period.

Key Market TrendsCondoms are Expected to Dominate the Contraceptive Devices Market

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2.0% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. They also to a lesser extent protect against genital herpes, human papillomavirus (HPV), and syphilis.

The increasing use of condoms and rising cases of sexually transmitted diseases in France are the major factors propelling the segment's growth. For instance, as per the report published by the World Population Review in February 2022, around 0.30% of the population of France had HIV in 2020. Similarly, as per the study titled, "High syphilis prevalence and incidence in people living with HIV and Preexposure Prophylaxis users: A retrospective review in the French Dat'AIDS cohort" published in May 2022, Syphilis prevalence and incidence were relatively high in France, especially among males who have sex with males with controlled HIV infection and pre-exposure prophylaxis users. The study also recommended that syphilis screening should be increased and behavioral risk reduction counseling among high-risk subjects should be conducted. Condoms are one of the essential requirements to lower the cases of sexually transmitted diseases in France.

Therefore, owing to the above-mentioned factors the segment is anticipated to witness a considerable growth rate over the forecast period.

Competitive Landscape

The market is moderately competitive and fragmented in nature. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known including AbbVie Inc. (Allergan), Bayer Healthcare, Cooper Surgical Inc. and Mylan Laboratories among others. Companies are undertaking strategic initiatives such as increasing investment in R&D of innovative products to gain a competitive edge from generic products available in the market.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.